{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T03:07:40Z","timestamp":1789182460998,"version":"build-2803163510"},"reference-count":43,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2022MH237"],"award-info":[{"award-number":["ZR2022MH237"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2023MH257"],"award-info":[{"award-number":["ZR2023MH257"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010029","name":"Taishan Scholar Foundation of Shandong Province","doi-asserted-by":"publisher","award":["tsqn202312352"],"award-info":[{"award-number":["tsqn202312352"]}],"id":[{"id":"10.13039\/501100010029","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012620","name":"Taishan Scholar Foundation of Shandong Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012620","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82371916"],"award-info":[{"award-number":["82371916"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.ejso.2026.111510","type":"journal-article","created":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T16:04:33Z","timestamp":1772294673000},"page":"111510","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Microwave ablation versus surgical resection for hepatocellular carcinoma within Milan criteria: A propensity score\u2013based analysis"],"prefix":"10.1016","volume":"52","author":[{"given":"Xu","family":"Qi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanbing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feier","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangxiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xujian","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ximing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5856-347X","authenticated-orcid":false,"given":"Xinya","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gongzheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejso.2026.111510_bib1","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1016\/S1470-2045(11)70175-9","article-title":"Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report","volume":"13","author":"Clavien","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejso.2026.111510_bib2","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","article-title":"EASL clinical practice guidelines: management of hepatocellular carcinoma","volume":"69","author":"Galle","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.ejso.2026.111510_bib3","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nrgastro.2016.193","article-title":"Liver transplantation for hepatocellular carcinoma: outcomes and novel surgical approaches","volume":"14","author":"Sapisochin","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.ejso.2026.111510_bib4","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.jhep.2018.12.027","article-title":"Outcomes of radiofrequency ablation as first-line therapy for hepatocellular carcinoma less than 3 Cm in potentially transplantable patients","volume":"70","author":"Doyle","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.ejso.2026.111510_bib5","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.jhep.2012.09.021","article-title":"Hepatocellular carcinoma locoregional therapies for patients in the waiting list. Impact on transplantability and recurrence rate","volume":"58","author":"Cescon","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.ejso.2026.111510_bib6","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jhep.2011.03.026","article-title":"Survival after radiofrequency ablation and salvage transplantation in patients with hepatocellular carcinoma and child-pugh a cirrhosis","volume":"56","author":"N'Kontchou","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.ejso.2026.111510_bib7","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1002\/hep.29098","article-title":"Radiofrequency ablation of hepatocellular carcinoma as bridge therapy to liver transplantation: a 10\u2010year intention\u2010to\u2010treat analysis","volume":"65","author":"Lee","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.ejso.2026.111510_bib8","doi-asserted-by":"crossref","DOI":"10.21037\/tgh.2016.03.04","article-title":"Bridging and downstaging therapy in patients suffering from hepatocellular carcinoma waiting on the list of liver transplantation","volume":"1","author":"She","year":"2016","journal-title":"Transl Gastroenterol Hepatol"},{"key":"10.1016\/j.ejso.2026.111510_bib9","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.cgh.2021.07.048","article-title":"National trends and waitlist outcomes of locoregional therapy among liver transplant candidates with hepatocellular carcinoma in the United States","volume":"20","author":"Kwong","year":"2022","journal-title":"Clin Gastroenterol Hepatol: Off Clin Pract J Am Gastroenterol Assoc"},{"key":"10.1016\/j.ejso.2026.111510_bib10","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(18)30010-2","article-title":"Hepatocellular carcinoma","volume":"391","author":"Forner","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.ejso.2026.111510_bib11","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S2468-1253(24)00434-5","article-title":"Precision surgery for hepatocellular carcinoma","volume":"10","author":"Magyar","year":"2025","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.ejso.2026.111510_bib12","article-title":"Liver resection and transplantation in the era of checkpoint inhibitors","volume":"6","author":"Tabrizian","year":"2024","journal-title":"JHEP Rep"},{"key":"10.1016\/j.ejso.2026.111510_bib13","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s11901-024-00641-y","article-title":"Indication of liver transplant for HCC: current status and future directions","volume":"23","author":"Horwitz","year":"2024","journal-title":"Curr Hepat Rep"},{"key":"10.1016\/j.ejso.2026.111510_bib14","article-title":"Optimal treatment for small HCC (<3 cm): resection, liver transplantation, or locoregional therapy?","volume":"5","author":"Wu","year":"2023","journal-title":"JHEP Rep"},{"key":"10.1016\/j.ejso.2026.111510_bib15","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ijsu.2020.06.050","article-title":"Liver resection in cirrhotic liver: are there any limits?","volume":"82","author":"Chan","year":"2020","journal-title":"Int J Surg"},{"key":"10.1016\/j.ejso.2026.111510_bib16","doi-asserted-by":"crossref","first-page":"3122","DOI":"10.1007\/s00464-020-07747-6","article-title":"Pathologic response translates to improved patient survival after locoregional treatment for hepatocellular carcinoma: the importance of minimally invasive microwave ablation","volume":"35","author":"Baimas-George","year":"2021","journal-title":"Surg Endosc"},{"key":"10.1016\/j.ejso.2026.111510_bib17","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1097\/SLA.0000000000000234","article-title":"Microwave ablation for hepatic malignancies: a multiinstitutional analysis","volume":"259","author":"Groeschl","year":"2014","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2026.111510_bib18","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.jvir.2022.05.019","article-title":"Microwave ablation as bridging to liver transplant for patients with hepatocellular carcinoma: a single-center retrospective analysis","volume":"33","author":"Couillard","year":"2022","journal-title":"J Vasc Intervent Radiol"},{"key":"10.1016\/j.ejso.2026.111510_bib19","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.jhep.2017.10.004","article-title":"Percutaneous treatment of hepatocellular carcinoma: state of the art and innovations","volume":"68","author":"Nault","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.ejso.2026.111510_bib20","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s00508-016-1046-1","article-title":"Indications for liver transplantation in adults: recommendations of the austrian society for gastroenterology and hepatology (\u00d6GGH) in cooperation with the austrian society for transplantation, transfusion and genetics (ATX)","volume":"128","author":"Graziadei","year":"2016","journal-title":"Wien Klin Wochenschr"},{"key":"10.1016\/j.ejso.2026.111510_bib21","doi-asserted-by":"crossref","unstructured":"Chu W, Li P, Wu X, Zhang P, Zhou H, Niu B. Risk factors for recurrence beyond milan criteria after radiofrequency ablation in transplantable small hepatocellular carcinoma. Rev Esp Enferm Dig (e-pub ahead of print 2022; doi:10.17235\/reed.2022.8592\/2022).","DOI":"10.17235\/reed.2022.8592\/2022"},{"key":"10.1016\/j.ejso.2026.111510_bib22","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/hep.29913","article-title":"Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the american association for the study of liver diseases","volume":"68","author":"Marrero","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.ejso.2026.111510_bib23","doi-asserted-by":"crossref","first-page":"4657","DOI":"10.1007\/s00330-022-08537-5","article-title":"Microwave ablation versus radiofrequency ablation for subcapsular hepatocellular carcinoma: a propensity score\u2013matched study","volume":"32","author":"Zheng","year":"2022","journal-title":"Eur Radiol"},{"key":"10.1016\/j.ejso.2026.111510_bib24","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1002\/hep.20465","article-title":"Initial response to percutaneous ablation predicts survival in patients with hepatocellular carcinoma","volume":"40","author":"Sala","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.ejso.2026.111510_bib25","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1148\/radiol.14132958","volume":"273","author":"Ahmed","year":"2014","journal-title":"Radiology"},{"key":"10.1016\/j.ejso.2026.111510_bib26","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","article-title":"Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey","volume":"240","author":"Dindo","year":"2004","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2026.111510_bib27","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/SLA.0b013e3181b13ca2","article-title":"The clavien-dindo classification of surgical complications: five-year experience","volume":"250","author":"Clavien","year":"2009","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2026.111510_bib28","doi-asserted-by":"crossref","DOI":"10.12659\/AOT.931980","article-title":"Clinical outcomes of ablation compared with resection for single hepatocellular carcinoma lesions, as a primary treatment or bridging to liver transplantation: a retrospective comparative study","volume":"26","author":"Ward","year":"2021","journal-title":"Ann Transplant"},{"key":"10.1016\/j.ejso.2026.111510_bib29","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.223135","article-title":"Outcomes following different thermal ablation strategies in patients with unresectable colorectal liver metastases","volume":"308","author":"Li","year":"2023","journal-title":"Radiology"},{"key":"10.1016\/j.ejso.2026.111510_bib30","doi-asserted-by":"crossref","unstructured":"Liang Y, Yang J, Li H, Wu J, Tan W, Ren Y, Li X, Li R, Wang X, Liu M, Zhou Q, Duan F. Efficacy and safety of TACE plus lenvatinib with PD-1 inhibitor for unresectable huge hepatocellular carcinoma: a multicenter retrospective cohort study. Int J Surg (e-pub ahead of print 4 December 2025; doi:10.1097\/JS9.0000000000004131).","DOI":"10.1097\/JS9.0000000000004131"},{"key":"10.1016\/j.ejso.2026.111510_bib31","doi-asserted-by":"crossref","DOI":"10.21037\/hbsn-2025-45","article-title":"Recurrence beyond milan criteria following liver resection for early-stage hepatocellular carcinoma: incidence, prediction and implications for treatment selection","volume":"14","author":"Tsilimigras","year":"2025","journal-title":"Hepatobiliary Surg Nutr"},{"key":"10.1016\/j.ejso.2026.111510_bib32","doi-asserted-by":"crossref","first-page":"205","DOI":"10.2147\/JHC.S505979","article-title":"Long-term analysis of recurrence beyond milan criteria following ablation of solitary early-stage hepatocellular carcinoma \u22643 Cm in potentially transplantable patients: a over 10-year survival study","volume":"12","author":"Chen","year":"2025","journal-title":"J Hepatocell Carcinoma"},{"key":"10.1016\/j.ejso.2026.111510_bib33","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.35066","article-title":"Survival outcomes among patients with hepatocellular carcinoma in a large integrated US health system","volume":"7","author":"Yilma","year":"2024","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ejso.2026.111510_bib34","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/lt.23798","article-title":"Risk factors for exceeding the milan criteria after successful radiofrequency ablation in patients with early-stage hepatocellular carcinoma","volume":"20","author":"Tsuchiya","year":"2014","journal-title":"Liver Transplant"},{"key":"10.1016\/j.ejso.2026.111510_bib35","doi-asserted-by":"crossref","first-page":"3796","DOI":"10.3390\/cancers12123796","article-title":"Microwave ablation versus radiofrequency ablation for treatment of hepatocellular carcinoma: a meta-analysis of randomized controlled trials","volume":"12","author":"Facciorusso","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.ejso.2026.111510_bib36","doi-asserted-by":"crossref","first-page":"4764","DOI":"10.1007\/s00330-020-07571-5","article-title":"Small single perivascular hepatocellular carcinoma: comparisons of radiofrequency ablation and microwave ablation by using propensity score analysis","volume":"31","author":"An","year":"2021","journal-title":"Eur Radiol"},{"key":"10.1016\/j.ejso.2026.111510_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2023.110860","article-title":"Microwave ablation versus radiofrequency ablation as bridge therapy in potentially transplantable patients with single HCC \u2264 3 cm: a propensity score-matched study","volume":"164","author":"Wang","year":"2023","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.ejso.2026.111510_bib38","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1097\/SLA.0000000000002360","article-title":"Prediction of hepatocellular carcinoma recurrence beyond milan criteria after resection: validation of a clinical risk score in an international cohort","volume":"266","author":"Zheng","year":"2017","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2026.111510_bib39","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1053\/j.gastro.2017.03.018","article-title":"American gastroenterological association institute clinical practice update\u2014expert review: care of patients who have achieved a sustained virologic response after antiviral therapy for chronic hepatitis C infection","volume":"152","author":"Jacobson","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejso.2026.111510_bib40","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1111\/liv.12991","article-title":"Post\u2010ablation des\u2010gamma\u2010carboxy prothrombin level predicts prognosis in hepatitis b\u2010related hepatocellular carcinoma","volume":"36","author":"Lee","year":"2016","journal-title":"Liver Int"},{"key":"10.1016\/j.ejso.2026.111510_bib41","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1080\/09674845.2018.1494769","article-title":"Monocyte\/granulocyte to lymphocyte ratio and the MELD score as predictors for early recurrence of hepatocellular carcinoma after trans-arterial chemoembolization","volume":"75","author":"Elalfy","year":"2018","journal-title":"Br J Biomed Sci"},{"key":"10.1016\/j.ejso.2026.111510_bib42","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ijsu.2020.03.006","article-title":"The efficacy of microwave ablation versus liver resection in the treatment of hepatocellular carcinoma and liver metastases: a systematic review and meta-analysis","volume":"77","author":"Yang","year":"2020","journal-title":"Int J Surg"},{"key":"10.1016\/j.ejso.2026.111510_bib43","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1186\/s12876-025-04081-w","article-title":"Efficacy and safety of ultrasound-guided percutaneous microwave ablation for hepatocellular carcinoma at specific anatomic sites of the liver: a systematic review and meta-analysis","volume":"25","author":"Fu","year":"2025","journal-title":"BMC Gastroenterol"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798326001290?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798326001290?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T03:02:38Z","timestamp":1789182158000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798326001290"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":43,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S0748798326001290"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2026.111510","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Microwave ablation versus surgical resection for hepatocellular carcinoma within Milan criteria: A propensity score\u2013based analysis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2026.111510","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111510"}}